aztreonam has been researched along with Infection, Wound in 6 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This research focuses on the feasibility of using silver- and fluoride-containing BGs against multidrug-resistant bacterial strains isolated from patients with burns." | 7.83 | Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. ( Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F, 2016) |
| " This research focuses on the feasibility of using silver- and fluoride-containing BGs against multidrug-resistant bacterial strains isolated from patients with burns." | 3.83 | Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. ( Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F, 2016) |
| "aeruginosa burn wound infection, aztreonam and piperacillin should be considered as the first line of defense." | 1.30 | The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa. ( Heggers, JP; Herndon, DN; Villarreal, C; Walton, MA, 1997) |
| " An investigation was therefore carried out to determine whether aztreonam, a synthetic monocyclic beta-lactam antibiotic, can safely be combined with cyclosporin." | 1.28 | Aztreonam can safely be used in combination with cyclosporin without aggravating nephrotoxicity. ( Hoitsma, AJ; Koene, RA; Rietbroek, RC, 1989) |
| "Aztreonam is a novel antimicrobial agent belonging to the monobactam class of antibiotics." | 1.27 | Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa. ( Neu, HC; Scully, BE, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gahane, AY | 1 |
| Singh, V | 1 |
| Kumar, A | 1 |
| Kumar Thakur, A | 1 |
| Gholipourmalekabadi, M | 1 |
| Sameni, M | 1 |
| Hashemi, A | 1 |
| Zamani, F | 1 |
| Rostami, A | 1 |
| Mozafari, M | 1 |
| Bonner, DP | 1 |
| Whitney, RR | 1 |
| Baughn, CO | 1 |
| Miller, BH | 1 |
| Olsen, SJ | 1 |
| Sykes, RB | 1 |
| Walton, MA | 1 |
| Villarreal, C | 1 |
| Herndon, DN | 1 |
| Heggers, JP | 1 |
| Rietbroek, RC | 1 |
| Hoitsma, AJ | 1 |
| Koene, RA | 1 |
| Scully, BE | 1 |
| Neu, HC | 1 |
6 other studies available for aztreonam and Infection, Wound
| Article | Year |
|---|---|
Development of mechanism-based antibacterial synergy between Fmoc-phenylalanine hydrogel and aztreonam.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Bacterial Load; Dipeptides; Disease | 2020 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ce | 2016 |
In-vivo properties of SQ 26,776.
Topics: Animals; Anti-Bacterial Agents; Aztreonam; Enterobacteriaceae Infections; Haemophilus influenzae; La | 1981 |
The use of aztreonam as an alternate therapy for multi-resistant Pseudomonas aeruginosa.
Topics: Aminoglycosides; Aztreonam; Burns; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Thera | 1997 |
Aztreonam can safely be used in combination with cyclosporin without aggravating nephrotoxicity.
Topics: Acute Kidney Injury; Ampicillin; Aztreonam; Cyclosporins; Drug Therapy, Combination; Humans; Kidney; | 1989 |
Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Arthritis, Infectious; Aztreonam; Bacterial Infectio | 1985 |